Latest News

Chalet Hotels Limited ( NSE:CHALET ) just released its latest quarterly results and things are looking bullish. Chalet...

When close to half the companies in India have price-to-earnings ratios (or "P/E's") below 23x, you may consider NOCIL...

Key Insights Significant control over Colgate-Palmolive (India) by public companies implies that the general public has...

Garware Hi-Tech Films Limited ( NSE:GRWRHITECH ) shares have had a really impressive month, gaining 39% after a shaky...

Kalyani Steels Limited's ( NSE:KSL ) price-to-earnings (or "P/E") ratio of 12.8x might make it look like a buy right...

Sun Pharmaceutical Industries Limited ( NSE:SUNPHARMA ) will increase its dividend on the 16th of February to ₹11.00...

The Bombay Dyeing and Manufacturing Company Limited ( NSE:BOMDYEING ) shareholders might be concerned after seeing the...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Corteva (CTVA) has wrapped up FY 2025 with Q4 revenue of US$3.9b and a basic EPS loss of US$0.80, while the trailing twelve month line shows revenue of US$17.4b and basic EPS of US$1.75, alongside earnings growth of 40.2% over the last year. Over recent periods, revenue has sat in a US$2.6b to US$6.5b quarterly range with EPS swinging between quarterly profits and losses, while on a trailing basis earnings are forecast to grow about 20.7% per year. With a trailing net margin of 6.9% versus 5%...

Galderma recently announced that the U.S. FDA has accepted its resubmitted Biologics License Application for RelabotulinumtoxinA, a neuromodulator for treating moderate-to-severe frown lines and crow’s feet in adults, following manufacturing process adjustments and backed by large phase III trial data. This milestone builds on Relfydess’s approvals in more than 20 markets and highlights Galderma’s efforts to broaden its injectable aesthetics franchise worldwide. We’ll now examine how the...

InnovAge Holding (INNV) has reported Q2 2026 results with revenue of US$239.7 million and basic EPS of US$0.08, alongside net income of US$10.6 million. Its trailing 12 month figures show revenue of US$915.4 million and basic EPS of US$0.05 on net income of US$6.5 million. The company’s quarterly revenue moved from US$209.0 million in Q2 2025 to US$239.7 million in Q2 2026, with basic EPS shifting from a loss of US$0.10 per share to a profit of US$0.08. This places improving margins and the...

DaVita (DVA) has just wrapped up FY 2025 with Q4 revenue of US$3.6b and basic EPS of US$3.00, supported by Q4 net income from continuing operations of about US$209 million and an additional US$25 million from discontinued operations. Over the past six quarters, the company has seen quarterly revenue move from US$3.3b in Q4 2024 to US$3.6b in Q4 2025, while basic EPS across that period ranged between roughly US$2.05 and US$3.18. This sets up a set of results where the key question for...

When close to half the companies in Korea have price-to-earnings ratios (or "P/E's") below 14x, you may consider Hanmi...

Azenta (AZTA) opened its Q1 2026 update with revenue of $148.6 million and a basic EPS loss of $0.11, setting a measured tone for the quarter. The company has seen quarterly revenue move within a relatively tight band, from $151.1 million in Q4 2024 to $147.5 million in Q1 2025, $143.4 million in Q2 2025, $143.9 million in Q3 2025, $159.0 million in Q4 2025 and now $148.6 million in Q1 2026. EPS swung from a small loss of $0.02 in Q4 2024 to a profit of $1.12 in Q4 2025 before returning to a...

CDW (CDW) has put fresh numbers on the table for FY 2025, with third quarter revenue of US$5.7b, basic EPS of US$2.22 and net income of US$291m, giving investors a clearer read on how the year is shaping up. The company has seen revenue move from US$5.2b in Q4 2024 to US$5.2b in Q1 2025, US$6.0b in Q2 2025 and US$5.7b in Q3 2025. Over the same period, quarterly EPS went from US$1.98 to US$1.70, US$2.06 and US$2.22, setting the scene for investors to focus on how these results tie back to...

Hanover Insurance Group (THG) has released its FY 2025 numbers with fourth quarter revenue of US$1,671.8 million and basic EPS of US$5.52, capped off by trailing twelve month revenue of US$6.6 billion and EPS of US$18.51. Over recent reporting periods the company has seen revenue move from US$1,584.3 million and EPS of US$4.65 in Q4 2024 to US$1,671.8 million and EPS of US$5.52 in Q4 2025. Trailing net income reached US$660.7 million and margins sat at 10% over the last year, giving investors...

Aurora Cannabis (TSX:ACB) just posted its Q3 2026 numbers, with revenue of $90.4 million and a basic EPS loss of $0.91, alongside net income from continuing operations showing a loss of $51.6 million. The company has seen quarterly revenue move in a relatively tight band between $81.1 million and $98.0 million since early 2025, while EPS has swung from a profit of $0.57 in Q3 2025 to losses in more recent quarters, including a $0.26 loss in Q1 2026. With the share price at $5.11 and margins...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

There wouldn't be many who think Saltware Co., Ltd.'s ( KOSDAQ:328380 ) price-to-sales (or "P/S") ratio of 0.6x is...

Cognizant Technology Solutions (CTSH) opened FY 2025 with Q1 revenue of US$5.1b and basic EPS of US$1.34, followed by Q2 revenue of US$5.2b and EPS of US$1.31, and then Q3 revenue of US$5.4b with EPS of US$0.56, setting a clear view of how the top and bottom line have tracked through the year. Over the past few quarters, revenue has moved from US$4.9b in Q2 2024 to US$5.1b in Q4 2024 and then to US$5.1b, US$5.2b and US$5.4b in Q1, Q2 and Q3 2025 respectively. Basic EPS shifted from US$1.14...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...

Over the past year, many Aussie Broadband Limited ( ASX:ABB ) insiders sold a significant stake in the company which...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...